INCB39110 5mg

INCB39110 is a potent JAK1 tyrosine kinase inhibitor, which is currently in Phase II trials for the treatment of rheumatoid arthritis, myelofibrosis, rheumatoid arthritis and plaque psoriasis.

Price Not Available 5mg INCB39110 5mg Supplier Page

Trivial name	INCB39110 5mg
Catalog Number	A14390-5
Alternative Name(s)	2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(1-(3-fluoro-2-(trifluoromethyl)isonicotinoyl)piperidin-4-yl)azetidin-3-yl)acetonitrile
Molecular Formula	C26H23F4N9O
CAS#	1334298-90-6
SMILES	N#CCC1(N2N=CC(C3=C4C(NC=C4)=NC=N3)=C2)CN(C5CCN(C(C6=C(F)C(C(F)(F)F)=NC=C6)=O)CC5)C1
Size	5mg
Supplier Page	http://www.adooq.com/incb39110.html